Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Truist lifts Medical Properties Trust stock target, keeps Hold rating

EditorNatashya Angelica
Published 08/04/2024, 19:16

On Monday, Truist Securities updated its outlook on Medical Properties Trust (NYSE:MPW), a real estate investment trust focusing on healthcare facilities. The firm's analyst has increased the price target for the stock to $4.50, up from the previous $4.00, while retaining a Hold rating on the shares.

The revision in the price target reflects minor adjustments to the firm's Funds From Operations (FFO) estimates for Medical Properties Trust. Despite the adjusted price target, the analyst highlighted the inherent uncertainty surrounding the company's future, acknowledging the lack of precision in the earnings estimates and price target.

The analyst noted that while lower interest rates and narrowing credit spreads could provide some benefit, it is anticipated that Medical Properties Trust may become a smaller entity with reduced earnings over time.

The stock has experienced significant volatility and a downward trend in its trading value. The analyst cited a range of potential outcomes for the stock, and due to the associated risks, Truist Securities refrains from recommending Medical Properties Trust to investors.

The largest operator within MPW's portfolio, Steward Health Care, which is privately held, has shifted to cash-basis accounting and is currently behind on rent payments. The analyst pointed out that recent trends and media coverage, including a critical article from March 21, have not been favorable towards Steward Health Care.

Medical Properties Trust management has previously expressed that they expect the Steward portfolio to either return to contributing to earnings or to act as a source of liquidity. The company is actively working towards its goal of securing $2 billion in liquidity for the year through asset sales, which will result in the reduction of the company's size.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The analyst also expressed concerns over the impending challenges of maturing low-interest-rate debt, which could pose a significant obstacle to earnings. The firm anticipates that addressing this debt will lead to material dilution, whether it is managed through refinancing or repayment from the proceeds of asset sales.

InvestingPro Insights

Amidst the challenges and uncertainties surrounding Medical Properties Trust (NYSE:MPW), recent data from InvestingPro provides a mixed outlook for the company. According to the latest real-time metrics, MPW's market capitalization stands at approximately $2.43 billion, with a high dividend yield of 14.81%, reflecting the company's commitment to returning value to shareholders.

This commitment is further evidenced by a history of maintaining dividend payments for 19 consecutive years, an InvestingPro Tip that highlights the firm's dedication to consistent shareholder returns despite market fluctuations.

On the performance front, MPW has shown resilience with a strong return over the last three months, boasting a 19.47% price total return. However, the broader picture reveals a significant price decline over the last five years.

The company's Price / Book multiple is currently low at 0.32, suggesting that the stock may be undervalued relative to its assets, which is another InvestingPro Tip that could catch the eye of value investors.

For investors seeking more in-depth analysis and additional InvestingPro Tips, there are 11 more tips available on InvestingPro for Medical Properties Trust. To access these insights and enhance your investment strategy, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at https://www.investing.com/pro/MPW.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.